AKT1 and breast cancer: Exosomal ABCG2 expression can be induced by the phosphoinositide-3-kinase–protein kinase B (PI3K)- protein kinase B (Akt) signaling pathway and inhibition of this pathway led to cytoplasmic re-localization of ABCG2 and increased drug sensitivity in breast cancer cells [23].